GSK ebola

Ended Definitive Contract Awarded Last action

Contract number
HHSO100201500003C
Awardee
Awarding agency
Obligated
$6,359,344

Award facts

Opportunity
Contract value 100% obligated
  • $6,359,344.07 Current, with exercised options
  • $6,375,970.07 Potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
NAICS code
541711 Research and Development in Biotechnology
PSC
AN13 Health R&D Services; Health Care Services; Experimental Development
Set-aside
No set-aside
Competition
Full and Open Competition · 20 offers Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee
Place of performance
Durham, NC 27709, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out P00003 · Modification 3: conclude final close-out activities through deobligation of $1,111,656.93 -$1,111,657
Funding Only Action 2 -$5,512,500
Change Order 1 $0
Original award $12,983,501

Quick answers

Who was awarded contract HHSO100201500003C?

HHSO100201500003C was awarded to Glaxosmithkline, LLC by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on December 23, 2014.

How much is contract HHSO100201500003C worth?

The government has obligated $6,359,344 on HHSO100201500003C. Its potential value, with all options, is $6,375,970.

Was contract HHSO100201500003C competed?

The extent of competition for HHSO100201500003C was full and open competition. The government received 20 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award